Inventor

SALIMU JOSEPHINE

GB19 patents

⚠️ This page may combine multiple inventors who share the name “SALIMU JOSEPHINE”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

TUSK THERAPEUTICS LTD

12 patents

US10752691B2Aug 25, 2020

Anti-CD25 antibody agents

TUSK THERAPEUTICS LTD12 citations93

US10745485B2Aug 18, 2020

Anti-CD25 antibody agents

TUSK THERAPEUTICS LTD11 citations93

US10738125B2Aug 11, 2020

Anti-CD25 antibody agents

TUSK THERAPEUTICS LTD11 citations93

US11787866B2Oct 17, 2023

Anti-CD25 antibody agents

TUSK THERAPEUTICS LTD1 citations72

US11697688B2Jul 11, 2023

Anti-CD25 for tumour specific cell depletion

TUSK THERAPEUTICS LTD1 citations72

US11814434B2Nov 14, 2023

Anti-CD25 for tumour specific cell depletion

TUSK THERAPEUTICS LTD0 citations62

US11802160B2Oct 31, 2023

Anti-CD25 antibody agents

TUSK THERAPEUTICS LTD0 citations62

US11802161B2Oct 31, 2023

Anti-CD25 for tumour specific cell depletion

TUSK THERAPEUTICS LTD0 citations62

US11919960B2Mar 5, 2024

Anti-CD25 antibody agents

TUSK THERAPEUTICS LTD0 citations61

US11873341B2Jan 16, 2024

Anti-CD25 for tumour specific cell depletion

TUSK THERAPEUTICS LTD0 citations61

US11851494B2Dec 26, 2023

Anti-CD25 for tumour specific cell depletion

TUSK THERAPEUTICS LTD0 citations61

US11879014B2Jan 23, 2024

Method of treating cancer or depleting regulatory T cells in a subject by administering a human IGG1 anti-CD25 antibody

TUSK THERAPEUTICS LTD0 citations56

Black Belt Therapeutics Ltd

7 patents

US12343394B2Jul 1, 2025

CD38 modulating antibody agents

Black Belt Therapeutics Ltd0 citations59

US12304964B2May 20, 2025

CD38 modulating antibody

Black Belt Therapeutics Ltd0 citations59

US12162949B2Dec 10, 2024

CD38 antibody

Black Belt Therapeutics Ltd0 citations59

US12161717B2Dec 10, 2024

CD38 modulating antibody agents

Black Belt Therapeutics Ltd0 citations59

US11780930B2Oct 10, 2023

CD38 modulating antibody

Black Belt Therapeutics Ltd0 citations59

US11542338B2Jan 3, 2023

CD38 modulating antibody

Black Belt Therapeutics Ltd1 citations59

US11236173B2Feb 1, 2022

CD38 antibody

Black Belt Therapeutics Ltd1 citations59